Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics

被引：20
|
作者：
Di, Biao [1 ]
Jia, Hongling [2 ]
Luo, Oscar Junhong [3 ]
Lin, Fangqin [4 ]
Li, Kuibiao [1 ]
Zhang, Yuanliang [5 ]
Wang, Huadong [6 ]
Liang, Huiying [7 ]
Fan, Jun [2 ]
Yang, Zhicong [1 ]
机构：
[1] Guangzhou Ctr Dis Control & Prevent, Guangzhou 510440, Guangdong, Peoples R China
[2] Jinan Univ, Sch Med, Dept Med Biochem & Mol Biol, Guangzhou 510632, Guangdong, Peoples R China
[3] Jinan Univ, Sch Med, Dept Syst Biomed Sci, Guangzhou 510632, Guangdong, Peoples R China
[4] Guangzhou Med Univ, GMU GIBH Joint Sch Life Sci, Guangzhou 511436, Guangdong, Peoples R China
[5] BGI Shenzhen Beishan Ind Zone, 11th Bldg, Shenzhen 518055, Guangdong, Peoples R China
[6] Jinan Univ, Sch Med, Key Lab Natl Adm Tradit Chinese Med Peoples Repub, Guangzhou 510632, Guangdong, Peoples R China
[7] Guangdong Gen Hosp, Guangdong Acad Med Sci, Clin Data Ctr, Guangzhou 510080, Guangdong, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2020年 / 5卷 / 01期
关键词：
D O I：
10.1038/s41392-020-00333-1
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
    Julkunen, Heli
    Cichonska, Anna
    Slagboom, P. Eline
    Wurtz, Peter
    ELIFE, 2021, 10
  • [42] Role of genetic factors in pneumonia and COVID-19
    Bertrams, Wilhelm
    Jung, Anna Lena
    Maxheim, Michael
    Schmeck, Bernd
    PNEUMOLOGE, 2021, 18 (04): : 212 - 217
  • [43] Validation study for assessing COVID-19 pneumonia treatments
    Lin, Kaibin
    Zhou, Bing
    Wu, Yi
    Wang, Zheng
    Li, Shu
    Li, Yuanyuan
    Li, Fen
    Xue, Yang
    Liu, Zirou
    Liao, Jiafen
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [44] Candida Pneumonia with Lung Abscess as a Complication of Severe COVID-19 Pneumonia
    Abdelhadi, Adel
    Kassem, Abeer
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 853 - 861
  • [45] ENDOTOXIN ADSORBANT THERAPY IN SEVERE COVID-19 PNEUMONIA
    Sirivongrangson, Phatadon
    Peerapornratana, Sadudee
    Tungsanga, Somkanya
    Tiankanon, Kanitha
    Kulvichit, Win
    Putcharoen, Opass
    Kellum, John A.
    Srisawat, Nattachai
    NEPHROLOGY, 2020, 25 : 40 - 40
  • [46] A rare case of COVID-19 pneumonia with severe hyperlipoproteinemia
    Shimoda, Masafumi
    Tanaka, Yoshiaki
    Morimoto, Kozo
    Kokutou, Hiroyuki
    Abe, Taro
    Suga, Miyuri
    Yoshiyama, Takashi
    Yoshimori, Kozo
    Ohta, Ken
    OXFORD MEDICAL CASE REPORTS, 2022, 2022 (04): : 132 - 134
  • [47] Bronchoalveolar lavage findings in severe COVID-19 pneumonia
    Guillaume Voiriot
    Anne Fajac
    Julien Lopinto
    Vincent Labbé
    Muriel Fartoukh
    Internal and Emergency Medicine, 2020, 15 : 1333 - 1334
  • [48] Severe covid-19 pneumonia: pathogenesis and clinical management
    Attaway, Amy H.
    Scheraga, Rachel G.
    Bhimraj, Adarsh
    Biehl, Michelle
    Hatipoglu, Umur
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [49] CYTOKINES ADSORBANT THERAPY IN SEVERE COVID-19 PNEUMONIA
    Sirivongrangson, Phatadon
    Tungsanga, Somkanya
    Tiankanon, Kanitha
    Peerapornratana, Sadudee
    Srisawat, Nattachai
    NEPHROLOGY, 2020, 25 : 40 - 40
  • [50] Invasive aspergillosis in patients with severe COVID-19 pneumonia
    Helleberg, Marie
    Steensen, Morten
    Arendrup, Maiken Cavling
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (01) : 147 - 148
12345